Editing Cardinal Health (section)

===FDA action===
In August 2006, Cardinal Health ceased production of its Alaris SE [[infusion pump]] after approximately 1300 units were seized{{Why|date=May 2022}} by the [[United States Food and Drug Administration]] (FDA).<ref name="fdaraid">{{cite web |url=http://cardinalhealth.mediaroom.com/newsreleasearchive?item=122451 |title=Cardinal Health Suspends Production of Alaris SE Infusion Pump Following FDA Actions |publisher=Cardinal Health |date=August 28, 2006 |access-date=June 13, 2018 |archive-date=April 18, 2021 |archive-url=https://web.archive.org/web/20210418145851/https://cardinalhealth.mediaroom.com/newsreleasearchive?item=122451 |url-status=dead }}</ref> In February 2007, Cardinal Health signed a [[consent decree]] with the FDA which promised procedures to guarantee the safety of the Alaris SE.<ref name="spinoff" /> After FDA inspections, Cardinal Health entered into a further consent agreement with the FDA in 2009.<ref name="spinoff" />